Pharmacokinetic based dosage change

DIAGNOSTIC_TEST2 trials

Sponsors

Hampshire Hospitals NHS Foundation Trust, Yves Pastore

Conditions

Severe Haemophilia ASickle Cell Disease (SCD)

Phase 2

Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia

RecruitingNCT06761560

Yves PastoreSickle Cell Disease (SCD)

Start: 2026-02-03End: 2028-11-25Target: 29Updated: 2026-08-21

Phase 4

Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A

CompletedNCT02697370

Hampshire Hospitals NHS Foundation TrustSevere Haemophilia A

Start: 2013-04-30End: 2015-05-31Updated: 2018-02-23